Skip to main content
Supplement ScienceSupplementScience

Types of NAC (N-Acetyl Cysteine): Forms & Bioavailability

Evidence:Strong
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
NAC Capsules/TabletsModerate (6-10% oral bioavailability)Standard supplement form — most commonly used for daily glutathione support
NAC Effervescent TabletsModerateDissolved in water — may be better tolerated for respiratory use
IV N-Acetyl Cysteine (Mucomyst)HighHospital use for acetaminophen overdose — not a supplement

NAC Capsules/Tablets

Bioavailability: Moderate (6-10% oral bioavailability). Best for: Standard supplement form — most commonly used for daily glutathione support.

NAC Effervescent Tablets

Bioavailability: Moderate. Best for: Dissolved in water — may be better tolerated for respiratory use.

IV N-Acetyl Cysteine (Mucomyst)

Bioavailability: High. Best for: Hospital use for acetaminophen overdose — not a supplement.

Find the best NAC (N-Acetyl Cysteine) for your needs
Ranked by form, bioavailability, and value
Full NAC (N-Acetyl Cysteine) Guide

References

  1. RCTGrant JE, Odlaug BL, Kim SW (2009). N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Archives of General Psychiatry. DOI PubMed
  2. ReviewRushworth GF, Megson IL (2014). Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacology & Therapeutics. DOI PubMed
  3. Meta-analysisViña I, Viña JR, Carranza M, Mariscal G (2025). Efficacy of N-Acetylcysteine in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis.. Nutrients. DOI PubMed
  4. Meta-analysisPapi A, Alfano F, Bigoni T, Mancini L, et al. (2024). N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses.. Archivos de bronconeumologia. DOI PubMed
  5. Winterlind EL, Malone SG, Setzer MR, Murphy MA, et al. (2024). N-acetylcysteine as a treatment for substance use cravings: A meta-analysis.. Addiction biology. DOI PubMed
  6. Meta-analysisPeng TR, Lin HH, Tseng TL, Huang YH, et al. (2024). Efficacy of N-acetylcysteine for patients with depression: An updated systematic review and meta-analysis.. General hospital psychiatry. DOI PubMed
  7. Koh A, Wong T, Adiamah A, Sanyal S (2024). Systematic review and meta-analysis of the effect of N-acetylcysteine on outcomes after liver resection.. ANZ journal of surgery. DOI PubMed
Show 3 more references
  1. Huang C, Kuo S, Lin L, Yang Y (2023). The efficacy of N-acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis.. Therapeutic advances in respiratory disease. DOI PubMed
  2. Kishi T, Sakuma K, Hatano M, Iwata N (2023). N-acetylcysteine for schizophrenia: A systematic review and meta-analysis.. Psychiatry and clinical neurosciences. DOI PubMed
  3. Nejati M, Dehghan P, Jamilian P, Zarezadeh M (2022). The effects of N-acetylcysteine on recovery biomarkers: A systematic review and meta-analysis of controlled trials.. Journal of food biochemistry. DOI PubMed